Evidence map›Paper›PMID 27533619›Full record

ArticleHepatology (Baltimore, Md.)2016

Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.

Hirohisa Okabe, Jing Yang, Kyle Sylakowski, Mladen Yovchev, Yoshitaka Miyagawa, Shanmugam Nagarajan, Maria Chikina, Michael Thompson, Michael Oertel, Hideo Baba and 2 more

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Wnt/β-Catenin Signaling in Liver Pathobiology.Annual review of pathology · 2025
    Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Hirohisa OkabeDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Jing YangDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Kyle SylakowskiDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Mladen YovchevDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Yoshitaka MiyagawaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Shanmugam NagarajanDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Maria ChikinaDepartment of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Michael ThompsonDepartment of Pediatrics, Nationwide Children's Hospital, Columbus, OH.
Michael OertelDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Hideo BabaDepartment of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.
Satdarshan P MongaDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Kari Nichole Nejak-BowenDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA. knnst5@pitt.edu.
University of Pittsburgh · USKumamoto University · JPNationwide Children's Hospital · US

Funding

Role of Wnt/Beta-Catenin Signaling in Liver DevelopmentR01DK062277 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Satdarshan Singh Monga · 2004 to 2026
$9.0M
Role and regulation of beta-catenin in cholestatic liver diseaseR01DK103775 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Satdarshan Singh Monga, Kari N Nejak-Bowen · 2015 to 2026
$4.8M
Targeting beta-catenin in liver pathology: Novel Interactions, Novel ParadigmsR01DK100287 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONGA, SATDARSHAN SINGH · 2013 to 2016
$1.3M
NIDDK NIH HHS R01 DK062277NIDDK NIH HHS R01 DK100287NIDDK NIH HHS R01 DK103775
6 · The paper itself

Abstract

Hepatic repair is directed chiefly by the proliferation of resident mature epithelial cells. Furthermore, if predominant injury is to cholangiocytes, the hepatocytes can transdifferentiate to cholangiocytes to assist in the repair and vice versa, as shown by various fate-tracing studies. However, the molecular bases of reprogramming remain elusive. Using two models of biliary injury where repair occurs through cholangiocyte proliferation and hepatocyte transdifferentiation to cholangiocytes, we identify an important role of Wnt signaling. First we identify up-regulation of specific Wnt proteins in the cholangiocytes. Next, using conditional knockouts of Wntless and Wnt coreceptors low-density lipoprotein-related protein 5/6, transgenic mice expressing stable β-catenin, and in vitro studies, we show a role of Wnt signaling through β-catenin in hepatocyte to biliary transdifferentiation. Last, we show that specific Wnts regulate cholangiocyte proliferation, but in a β-catenin-independent manner.

conclusionWnt signaling regulates hepatobiliary repair after cholestatic injury in both β-catenin-dependent and -independent manners. (Hepatology 2016;64:1652-1666).

Indexed as

Cholestasis, IntrahepaticAnimalsbeta CateninCell Line, TumorCell TransdifferentiationHepatocytesHumansLiver RegenerationMiceSignal TransductionWnt Proteinsbeta CateninWnt Proteins

Identifiers

PMID27533619
PMCPMC5074849
OpenAlexW2510790529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.